Cargando…
Iron-Hepcidin Dysmetabolism, Anemia and Renal Hypoxia, Inflammation and Fibrosis in the Remnant Kidney Rat Model
Anemia is a common complication of chronic kidney disease (CKD) that develops early and its severity increases as renal function declines. It is mainly due to a reduced production of erythropoietin (EPO) by the kidneys; however, there are evidences that iron metabolism disturbances increase as CKD p...
Autores principales: | Garrido, Patrícia, Ribeiro, Sandra, Fernandes, João, Vala, Helena, Bronze-da-Rocha, Elsa, Rocha-Pereira, Petronila, Belo, Luís, Costa, Elísio, Santos-Silva, Alice, Reis, Flávio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395008/ https://www.ncbi.nlm.nih.gov/pubmed/25867633 http://dx.doi.org/10.1371/journal.pone.0124048 |
Ejemplares similares
-
Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia
por: Garrido, Patrícia, et al.
Publicado: (2015) -
Iron as the Key Modulator of Hepcidin Expression in Erythroid Antibody-Mediated Hypoplasia
por: Fernandes, J. C., et al.
Publicado: (2014) -
Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients
por: Belo, Luís, et al.
Publicado: (2019) -
Potential Cardiovascular Risk Protection of Bilirubin in End-Stage Renal Disease Patients under Hemodialysis
por: do Sameiro-Faria, Maria, et al.
Publicado: (2014) -
Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study
por: do Sameiro-Faria, Maria, et al.
Publicado: (2013)